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Abstract: In pregnancy, maternal physiology is subject to considerable adaptations, including
alterations in cardiovascular and metabolic function as well as development of immunological
tolerance towards the fetus. In an oocyte donation pregnancy, the fetus is fully allogeneic towards
the mother, since it carries both oocyte donor antigens and paternal antigens. Therefore, oocyte
donation pregnancies result in an immunologically challenging pregnancy, which is reflected
by a higher-than-normal risk to develop pre-eclampsia. Based on the allogeneic conditions in
oocyte donation pregnancies, we hypothesized that this situation may translate into alterations in
concentration of stable readouts of constituents of the reactive species interactome (RSI) compared to
normal pregnancies, especially serum free thiols, nitric oxide (NO) and hydrogen sulfide (H2S) related
metabolites. Indeed, total free thiol levels and nitrite (NO2−) concentrations were significantly lower
whereas protein-bound NO and sulfate (SO42−) concentrations were significantly higher in both
oocyte donation and naturally conceived pregnancies complicated by pre-eclampsia. The increased
concentrations of nitrite observed in uncomplicated oocyte donation pregnancies suggest that
endothelial NO production is compensatorily enhanced to lower vascular tone. More research is
warranted on the role of the RSI and bioenergetic status in uncomplicated oocyte donation pregnancies
and oocyte donation pregnancies complicated by pre-eclampsia.
Keywords: oocyte donation; reactive species interactome; thiols; nitric oxide; hydrogen sulfide;
pre-eclampsia
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1. Introduction
In pregnancy, maternal physiology is subject to considerable adaptation, including alterations in
cardiovascular and metabolic function as well as development of immunological tolerance towards
the fetus [1–4]. In a naturally conceived pregnancy, the fetus can be considered semi-allogeneic since it
carries both paternal and maternal antigens [5]. Although the semi-allogeneic conceptus is recognized
by the maternal immune system, as reflected by the presence of allo-antibodies directed against
paternal antigens in the maternal circulation, the conceptus is tolerated rather than rejected [6–9].
Furthermore, fetal cells are in direct contact with maternal cells at the fetal–maternal interface [7,10,11].
Oocyte donation is an artificial reproductive technique that enables women without ovarian
activity or diminished ovarian reserve to conceive [12]. Furthermore, women with a serious genetic
disease can choose to use oocytes of a healthy donor. In an oocyte donation pregnancy, the fetus
is fully allogeneic towards the mother, since it carries both oocyte donor antigens and paternal
antigens; this antigenic dissimilarity in unmatched oocyte donation pregnancies is comparable to
the antigenic dissimilarity in unmatched organ transplantation [5]. Due to the enhanced allogeneic
nature of oocyte donation, these pregnancies presumably need more or different maternal immune
adaptations, compared to naturally conceived pregnancies [5,13–15]. The increased adaptive load on
the immune system between naturally conceived and oocyte donation pregnancies may explain why
the latter are more often accompanied by immune-disturbance related obstetrical complications, such
as pregnancy induced hypertension and pre-eclampsia [13,15,16]. Oocyte donation pregnancies more
often coincide with other risk factors for pregnancy complications, such as the self-evident need for
artificial reproductive techniques, advanced maternal age, primiparity, cause of infertility, and multiple
gestations [17–21]. However, several studies have shown that the allogeneic nature of oocyte donation
itself is an independent risk factor for pre-eclampsia [16,22–26].
Pre-eclampsia is a syndrome of pregnancy that is characterised by hypertension and problems
in multiple organ systems [27,28]. It is caused by a hypoxic placenta which results in an aberrant
placental production of pro-inflammatory cytokines and anti-angiogenic factors. This translates
into an enhanced systemic inflammatory status, systemic angiogenic imbalance and subsequently,
in generalised endothelial dysfunction eventually resulting in the manifestation of clinical symptoms
of pre-eclampsia [17,28]. Since hypoxia, inflammation and vascular stress are accompanied by an
aberrant production of reactive oxygen species (ROS), as is the case in many other disease processes [29],
an enhanced presence of ROS may play a central role in pre-eclampsia. The placental tissue itself
is an important site of production of ROS and other reactive species; indeed, the pre-eclamptic
placenta is characterised by an increased production of reactive species [30–32]. This aberrant placental
production of ROS and reactive nitrogen species (RNS) may conceivably contribute to systemic
endothelial dysfunction in pre-eclampsia [33–36] and is likely to be accompanied by corresponding
changes in the production of reactive sulfur species (RSS).
The gasotransmitters nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H2S)
are important for vascular adaptations in pregnancy [37]. Gasotransmitters are known to regulate
angiogenesis and vascular tone and their production is linked to the regulation of antioxidant status;
the abnormal production of these small molecules is associated with pre-eclampsia [34,38–40]. Many of
these reactive small molecules (some of which belong to the group of gasotransmitters) are known
to chemically interact with each other [41]. Furthermore, ROS, RNS and RSS also react with other
biological targets such as thiol (SH) groups of enzymes, transcription factors and ion channels, which
enables sensing and adaptation processes of cells and tissues to changes in environmental conditions
and/or metabolic demand. This interaction of reactive species with other small molecules and
biological targets has been defined as the “reactive species interactome” (RSI) [41].
In allograft organ transplantation, systemic redox status predicts graft survival and
mortality [42–44], and reduced oxidative damage is associated with a better kidney transplant
outcome [45]. Based on the allogeneic conditions in oocyte donation pregnancies, we hypothesized
that the RSI status is affected in oocyte donation pregnancies. Therefore, we evaluated the RSI status,
Int. J. Mol. Sci. 2019, 20, 1150 3 of 15
measured by quantifying circulating total free thiols, total 8-iso-prostaglandin F2a, and metabolites of
the NO and H2S pathway in naturally conceived and oocyte donation pregnancies, in the absence and
presence of concomitant pre-eclampsia.
2. Results
2.1. Study Participants, Pregnancy Characteristics and Fetal Characteristics
Seventy-nine pregnant women were included in this case-control study; 23 women experienced
an uncomplicated naturally conceived pregnancy, 24 women had a naturally conceived pregnancy
complicated by pre-eclampsia, 27 women experienced an uncomplicated oocyte donation pregnancy,
and 5 women had an oocyte donation pregnancy complicated by pre-eclampsia. Characteristics of
study participants are summarized in Table 1.
Maternal age was significantly lower in uncomplicated naturally conceived pregnancies and
naturally conceived pregnancies complicated by pre-eclampsia compared to uncomplicated oocyte
donation pregnancies and oocyte donation pregnancies complicated by pre-eclampsia. BMI, smoking
habits, gravidity, and parity were comparable among groups. Moreover, obstetrical history was
comparable among groups. Only the number of previous miscarriages was significantly different
across groups (overall test, p < 0.05). Women experiencing an uncomplicated pregnancy were more
likely to have had uncomplicated pregnancies before. Of the uncomplicated pregnancies, three
women developed gestational hypertension after a naturally conceived pregnancy and four women
who were pregnant after oocyte donation had hypertension. None of these women fulfilled the
International Society for the study of Hypertension in Pregnancy (ISSHP) criteria for the diagnosis of
pre-eclampsia; the women with gestational hypertension had no other obstetric problems, and their
fetal growth was adequate for the gestational age [28]. Diastolic blood pressure in uncomplicated
oocyte donation pregnancies was significantly higher compared to naturally conceived uncomplicated
pregnancies. None of the women in our study had gestational diabetes or a history of gestational
diabetes. Fetal sex was comparable among groups. Birthweight of fetuses born after a pregnancy
complicated by pre-eclampsia was significantly lower compared to uncomplicated pregnancies.
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Table 1. Patient characteristics, obstetrical history, pregnancy characteristics and fetal characteristics.
ART Naturally Conceived Oocyte Donation Naturally Conceived Oocyte Donation
Complication Uncomplicated Uncomplicated Pre-Eclampsia Pre-Eclampsia
Maternal characteristics n = 23 n = 27 n = 24 n = 5 Overall sig.
Maternal Age (years), mean (SD) 31.8 (5.2) 41.1 (6.4) * 30.8 (5.8) 40.0 (7.2) # p < 0.001 a
BMI (kg/m2), median (range) 25.1 (18.8–37.8) 24.3 (16.9–31.6) 24.6 (19.3–36.8) 25.3 (20.7–27.2) ns a
Smoking, number (%) 2 (9.5) 1 (5) 6 (26.1) 1 (20.0) ns c
Gravidity, median (range) 1 (1–8) 2 (1–8) 1 (1–5) 1 (1–10) ns a
Gravidity 1, number (%) 12 (52.2) 9 (36.0) 14 (58.3) 3 (60.0) ns c
Parity, median (range) 0 (0–3) 0 (0–1) 0 (0–4) 0 (0–0) ns a
Parity 0, number (%) 13 (56.5) 15 (60.0) 19 (79.2) 5 (100) ns c
Obstetrical history n = 11 n = 15 n = 10 n = 2
Previous pregnancies n = 26 n = 39 n = 15 n = 10
Miscarriage, number (%) 8 (30.8) 27 (69.2) 7 (46.7) 8 (80.0) p < 0.05 c
Abortion, number (%) 1 (3.8) 0 1 (6.7) 0 ns c
EUG, number (%) 0 3 (7.7) 0 2 (20) ns c
TOP, number (%) 0 0 1 (6.7) 0 ns c
Pre-term birth, number (%) 0 2 (5.1) 1 (6.7) 0 ns c
IUFD, number (%) 0 0 1 (6.7) 0 ns c
Gestational hypertension, number (%) 0 2 (5.1) 1 (6.7) 0 ns c
Pre-eclampsia, number (%) 0 0 1 (6.7) 0 ns c
Gestational diabetes, number (%) 0 0 0 0
Pregnancies without complications, number (%) 17 (65.4) 5 (12.8) * 3 (20) * 0 p < 0.05 c
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Table 1. Cont.
ART Naturally Conceived Oocyte Donation Naturally Conceived Oocyte Donation
Complication Uncomplicated Uncomplicated Pre-Eclampsia Pre-Eclampsia
Pregnancy characteristics
ART, number (%) 0 27 (100) * 0 5 (100) # p < 0.001 c
Hypertension, number (%) 3 (13.6) 4 (17.4) 24 (100) * 5 (100) & p < 0.001 c
Highest diastolic BP, (mmHg), mean (SD) 74 (10) 82 (10) * 101 (9) * 101 (11) & p < 0.001 a
Proteinuria, number (%) 0 0 23 (95.8) * 5 (100) & p < 0.001 c
Pre-eclampsia, number (%) 0 0 24 (100) * 5 (100) & p < 0.001 c
HELLP-syndrome, number (%) 0 0 4 (16.7) * 0 p = 0.022 c
Gestational age (days), median (range (days)) 275 (269–290) 279 (231–290) 243 (198–283) * 217 (204–270) & p < 0.001 a
Preterm birth, number (%) 0 1 (4.2) 18 (75.0) * 4 (80.0) & p < 0.001 c
Gestational diabetes, number (%) 0 0 0 0
Delivery, vaginal, number (%) 6 (26.1) 11 (45.8) 12 (50.0) 1 (25.0)
Delivery, CS, number (%) 17 (73.9) 13 (54.2) 12 (50.0) 3 (75.0) ns c
Twin, number (%) 0 2 (7.4) 0 1 (20.0) ns c
Fetal characteristics n = 23 n = 29 n = 24 n = 6
Sex, male/female (%male) 16/7 (69.6) 10/18 (35.7) * 14/10 (58.3) 3/3 (50.0) ns c
Birthweight (gram), median (range) 3455 (2445–4415) 3500 (1611–4500) 2372 (705–4030) * 1319 (1100–3855) & p < 0.001 a
Small for gestational age, number (%) 1 (4.3) 5 (19.2) 10 (41.7) * 3 (50.0) p < 0.01 c
ART, artificial reproductive technique; BP, blood pressure; CS, caesarean section; EUG, extra uterine gravidity; IUFD, intra uterine fetal demise; ns, not significant; TOP, termination
of pregnancy. * significantly different compared to uncomplicated naturally conceived pregnancies, p < 0.05. # significantly different compared to naturally conceived pregnancies
complicated with pre-eclampsia, p < 0.05. & significantly different compared to uncomplicated oocyte donation pregnancies, p < 0.05. Statistical tests: a ANOVA, Post-Hoc test, LSD or
Tamhane when applicable, c Pearson chi-square, when applicable Fisher’s exact test for subgroup analysis.
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2.2. Presence of Oxidative Stress
The concentrations of both total free thiols and total 8-iso-prostaglandin F2a in blood are a measure
of redox stress. Protein-bound free thiols may function as a buffer system for a number of reactive
species and may also fulfil specific transport functions. Total (free and bound) 8-iso-prostaglandin F2a
is a product of lipid oxidation and indicative of systemic oxidative stress. Total free thiol concentrations
were lower in pregnancies complicated by pre-eclampsia, both after naturally conceived pregnancies
and oocyte donation pregnancies, compared to uncomplicated pregnancies of either type (Figure 1A,
p < 0.001). Furthermore, total free thiol concentrations revealed a weak positive association with
gestational age in naturally conceived pregnancies complicated by pre-eclampsia (Figure 1B; r = 0.453,
p < 0.05). Serum levels of total 8-iso-prostaglandin F2a did not differ among groups (Figure 1C).
Int. J. Mol. Sci. 2019, 20, 1150 5 of 14 
 
  
Figure 1. Indicators of oxidative stress. (A) Total free thiol concentrations were lower in pregnancies 
complicated by pre-eclampsia compared to controls and uncomplicated oocyte donation pregnancies 
(all, p < 0.001). (B) Total free thiol concentrations were positively correlated with gestational age in 
naturally conceived pregnancies complicated by pre-eclampsia (r = 0.453, * p < 0.05). (C) Total 8-iso-
prostaglandin F2a concentrations in serum did not differ between groups. NC, uncomplicated 
naturally conceived pregnancies; OD, uncomplicated oocyte donation pregnancies; NCPE, naturally 
conceived pregnancies complicated by pre-eclampsia; ODPE, oocyte donation pregnancies 
complicated by pre-eclampsia. * p < 0.05, *** p < 0.001. 
2.3. Nitric Oxide Pathway 
Nitric oxide (NO) is an important cellular messenger produced by the oxidation of L-arginine 
by nitric oxide synthases (NOS). In addition to its acute local production, NO bound to circulating 
proteins, such as serum albumin, can function as a storage and transport system of bioactive NO 
[46,47]; nitrite (NO2−) and nitrate (NO3−) are the major oxidation products of NO, but are also 
contained in food. The concentration of protein bound NO (RxNO) was higher in pregnancies 
complicated by pre-eclampsia (Figure 2A, p < 0.01). Interestingly, diastolic blood pressure correlated 
inversely with RxNO concentrations in women with an uncomplicated naturally conceived 
pregnancy (Figure 2B). Nitrite concentrations were lower in naturally conceived pregnancies 
complicated by pre-eclampsia and oocyte donation pregnancies complicated by pre-eclampsia 
compared to uncomplicated naturally conceived pregnancies and uncomplicated oocyte donation 
pregnancies, respectively. Also, circulating nitrite was higher in uncomplicated oocyte donation 
pregnancies compared to uncomplicated naturally conceived pregnancies (Figure 2C). Moreover, 
diastolic blood pressures were higher in women with an uncomplicated oocyte donation pregnancy 
and serum nitrite levels below the median of 0.168 µM compared to women with a serum nitrite level 
above the median (Figure 2D, p < 0.05). Nitrate concentrations were not significantly different across 
groups (Figure 2E). 
Figure 1. Indicators of oxidative stress. (A) Total free thiol concentrations were lower in pregnancies
complicated by pre-eclampsia compared to controls and uncomplicated oocyte donation pregnancies
(all, p < 0.001). (B) Total free thiol concentrations were positively correlated with gestational age
in naturally conceived pr gnancies co licated by pre-eclampsia (r = .453, * p < 0.05). (C) Total
8-iso-prostaglandin F2a concentrations in serum did not differ between groups. NC, uncomplicated
naturally conceived pregnancies; OD, uncomplicated oocyte donation pregnancies; NCPE, naturally
conceived pregnanci s complicated by pre-eclampsia; ODPE, oocyte donation pregnancies complicated
by pre-eclampsia. * p < 0.05, *** p < 0.001.
2.3. Nitric Oxide Pathway
Nitric oxid (NO) is an i porta t cellular messenger produced by the oxidation of L-arginine
by nitric oxide synthases (NOS). In addition to its acute local production, NO bound to circulating
proteins, such as serum albumin, can function as a storage and transport system of bioactive NO [46,47];
nitrite (NO2−) and nitrate (NO3−) a e the maj r oxidatio pr ducts of NO, but ar also contained
in food. The concentration of protein bound NO (RxNO) was higher in pregnancies complicated by
pre-eclampsia (Figure 2A, p < 0.01). Interestingly, diastolic blood pressure correlated inversely with
RxNO concentration in wom n with an uncomplicated naturally con eived pr gnancy (Figure 2B).
Nitrite concentrations were lower in naturally conceived pregnancies complicated by pre-eclampsia
and oocyte donation pregnancies complicated by pre-eclampsia compared to uncomplicated naturally
conceived pregnancies and uncomplicated oocyte donation pr gnancies, respectiv ly. Al o, circulating
nitrite was higher in uncomplicated oocyte donation pregnancies compared to uncomplicated naturally
conceived pregnancies (Figure 2C). Moreover, diastolic blood pressures were higher in women
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with an uncomplicated oocyte donation pregnancy and serum nitrite levels below the median of
0.168 µM compared to women with a serum nitrite level above the median (Figure 2D, p < 0.05).
Nitrate concentrations were not significantly different across groups (Figure 2E).Int. J. Mol. Sci. 2019, 20, 1150 6 of 14 
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0.001). (D) Patients in the uncomplicated oocyte donation group were divided into two groups based 
on the nitrite serum levels: One group contained serum nitrite values below the median of 0.168 uM, 
while the other group contained serum nitrite values above the median. Diastolic blood pressure was 
found to be higher in women with serum nitrite values below the median compared to women with 
a serum nitrite values above the median (* p < 0.05). (E) Nitrate (NO3−) concentrations did not differ 
between groups. NC, uncomplicated naturally conceived pregnancies; OD, uncomplicated oocyte 
Figure 2. Readouts of the nitric oxide (NO) pathway. (A) The concentrations of protein bound NO
(RxNO) were higher in pregnancies complicated by pre-eclampsia (** p < 0.01). (B) Diastolic blood pressure
was inversely associated with RxNO in uncomplicated naturally conceived pregnancies (r = −0.556,
* p < 0.05). (C) Nitrite (NO2−) concentrations were lower in naturally conceived pregnancies complicated by
pre-eclampsia and oocyte donation pregnancies complicated by pre-eclampsia compared to uncomplicated
naturally nceived pregnanc es and uncomplicated oocyte donatio pregnancies, respec ively (** p < 0.01
and *** p < 0.001). Nitrite levels were higher in uncomplicated oocyt donation pregna ies compared to
uncomplicated naturally conceived pregnancies (*** p < 0.001). (D) Patients in the uncomplicated oocyte
donation group were divided into two groups based on the nitrite serum levels: One group contained
serum nitrite values below the median of 0.168 uM, while the other group contained serum nitrite values
above the median. Diastolic blood pressure was found to be higher in women with serum nitrite values
below the m dian compared to women with a serum nitrite values above the medi n (* p < 0.05). (E) Nitrate
(NO3−) concentrations did not differ betwee groups. NC, uncomplicated naturally conceiv pregnancies;
OD, uncomplicated oocyte donation pregnancies; NCPE, naturally conceived pregnancies complicated by
pre-eclampsia; ODPE, oocyte donation pregnancies complicated by pre-eclampsia. * p < 0.05, ** p < 0.01,
*** p < 0.001.
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2.4. Hydrogen Sulfide Pathway
Thiosulfate (S2O32−) and sulfate (SO42−) are oxidative metabolites of hydrogen sulfide (H2S) and
dietary constituents. Serum sulfate concentrations were higher in both naturally conceived pregnancies
and oocyte donation pregnancies complicated by pre-eclampsia compared to uncomplicated naturally
conceived pregnancies and uncomplicated oocyte donation pregnancies (Figure 3A; both, p < 0.001).
Sulfate (SO4−) concentrations correlated positively with gestational age in naturally conceived
pregnancies complicated by pre-eclampsia (Figure 3B; r = 0.416, p < 0.05). By contrast, thiosulfate
(S2O32−) concentrations did not differ across groups (Figure 3C).
Int. J. Mol. Sci. 2019, 20, 1150 7 of 14 
 
donation pregnancies; NCPE, naturally conceived pregnancies complicated by pre-eclampsia; ODPE, 
oocyte donation pregnancies complicated by pre-eclampsia. * p < 0.05, ** p < 0.01, *** p < 0.001. 
2.4. Hydrogen Sulfide Pathway 
Th osulfate (S2O32−) and sulfate (SO42−) are oxidative metabolites of hydrogen sulf d  (H2S) and 
dietary constituents. Serum sulfate concentrations were higher in both aturally conceived 
pregnancies and oocyte donation pregnancies complicated by pre-eclampsia compared to 
uncomplicated naturally conceived pregnancies and uncomplicated oocyte donation pregnancies 
(Figure 3A; both, p < 0.001). Sulfate (SO4−) concentrations correlated positively with gestational age in 
naturally conceived pregnancies complicated by pre-eclampsia (Figure 3B; r = 0.416, p < 0.05). By 
contrast, thiosulfate (S2O32−) concentrations did not differ across groups (Figure 3C). 
 
Figure 3. Readouts of the hydrogen sulfide (H2S) pathway. (A) Sulfate (SO42−) values were higher in 
naturally conceived pregnancies complicated by pre-eclampsia compared to uncomplicated naturally 
conceived pregnancies and uncomplicated oocyte donation pregnancies (*** p < 0.001). (B) Sulfate 
(SO4−) values correlated positively with gestational age in naturally conceived pregnancies 
complicated by pre-eclampsia (r = 0.416, * p < 0.05). (C) Thiosulfate (S2O32−) values did not differ 
between groups. NC, uncomplicated naturally conceived pregnancies; OD, uncomplicated oocyte 
donation pregnancies; NCPE, naturally conceived pregnancies complicated by pre-eclampsia; ODPE, 
oocyte donation pregnancies complicated by pre-eclampsia. * p < 0.05, *** p < 0.001. 
3. Discussion 
In this observational study, we evaluated the RSI status in naturally conceived and oocyte 
donation pregnancies in the absence and presence of pre-eclampsia. Naturally conceived and oocyte 
donation pregnancies complicated by pre-eclampsia appear to be characterized by systemic redox 
stress; total free thiol levels and nitrite concentrations were significantly lower, whereas protein 
bound NO and sulfate concentrations were significantly higher in pregnancies complicated by pre-
eclampsia compared to uncomplicated pregnancies. Some of these changes have been described 
before in women with pre-eclampsia [48–50]. However, the literature is inconsistent [51,52]. The 
Figure 3. R adouts f the hydrogen sulfide (H2S) pathway. (A) S lf t ( 42−) values were igher in
naturally conceived pregnancies complicated by pre-ecla psia co pared to uncomplicated naturally
conceived pregnancies and uncomplicated oocyte donation pregnancies (*** p < 0.001). (B) Sulfate
(SO4−) values correlated positively with gestational age in naturally conceived pregnancies complicated
by pre-eclampsia (r = 0.416, * p < 0.05). (C) Thiosulfate (S2O32−) values did not differ between
groups. NC, uncomplicated naturally conceived pregnancies; OD, uncomplicated oocyte donation
pregnancies; NCPE, naturally conceived pregnancies complicated by pre-eclampsia; ODPE, oocyte
donation pregnancies complicated by pre-eclampsia. * p < 0.05, *** p < 0.001.
3. Discussion
In this observational study, we evaluated the RSI status in naturally conceived and oocyte
donation pregnancies in the absenc and resence of pre-eclampsia. N turally conceived and ocyte
donation pregnanci s c mplicated by pr -eclampsia appear to be characterized by systemic redox
stress; t tal free thiol levels and nitrite conc ntrations were significantly lower, whereas protein bound
NO and sulfate concentrations were significantly higher in pregnancies complicated by pre-eclampsia
compared to uncomplicated pregnancies. Some of these changes have been described before in
women with pre-eclampsia [48–50]. However, the literature is inconsistent [51,52]. The hypoxic
placenta is known to produce higher fluxes of ROS [30–32] and the same is true for the endothelium
of women with pre-eclampsia [36]. Since superoxide anions (O2−), an important ROS, directly react
with NO to produce peroxynitrite (ONOO−), enhanced oxidative stress typically translates into lower
Int. J. Mol. Sci. 2019, 20, 1150 9 of 15
NO bioavailability. Consistent with this paradigm, a reduced bioavailability of NO is known to be
involved in the development of generalised endothelial dysfunction and hypertension in women with
pre-eclampsia [35]. More recently, oxidative stress-induced S-glutathionylation of endothelial nitric
oxide synthase has been suggested to account for impaired NO production in the placenta [53]. We have
shown that the concentrations of free thiols and sulfate appear to positively correlate with gestational
age in naturally conceived pregnancies complicated by pre-eclampsia. While these associations are
modest, they would seem to be consistent with the notion that perturbations in systemic redox status
are tightly linked to the development of pre-eclampsia; a shorter gestational age in women with
pre-eclampsia is mainly due to iatrogenic birth (caesarean section or induction of labour) based on
the fetal or maternal condition, and is therefore always directly associated with the severity of the
disease. Both source and utilization of sulfate deserve further study in this context, as this anion is
not only the final oxidation product of H2S, but also an important nutrient for human growth and
development [54]. This is particularly important in view of the limited capacity of fetal tissues to
produce sulfate, thereby relying almost entirely on its supply via the maternal circulation.
In oocyte donation pregnancies, the fetus could be completely allogeneic to the gestational
carrier [5]. This condition is thus comparable with the situation of antigenic dissimilarity present in
organ transplantation [5,13]. Based on the immunogenic dissimilarity in oocyte donation, and what
is known from the redox status in transplantation, one might expect more oxidative stress in oocyte
donation pregnancies. However, total free thiol and total 8-iso-prostaglandin F2a concentrations were
not changed in uncomplicated oocyte donation pregnancies compared to uncomplicated naturally
conceived pregnancies. Curiously, increased nitrite concentrations were observed in uncomplicated
oocyte donation pregnancies compared to naturally conceived pregnancies. Circulating nitrite levels
are a reliable biomarker of endothelial NO production [55,56]. NO is a potent vasodilator and an
important regulator of vascular tone, and upregulated NO production could reduce blood pressure and
the development of hypertension [37,43,57]. However, this would be expected to be accompanied by a
concomitant increase in circulating nitrate (NO3−) concentrations. Diastolic blood pressure was slightly
higher in uncomplicated oocyte donation pregnancies compared to uncomplicated naturally conceived
pregnancies (Table 1, p < 0.05). Upregulation of NO/nitrite in oocyte donation could be a compensatory
mechanism to limit further increases in blood pressure in these women. This is supported by the
inverse association between diastolic blood pressure and protein bound NO (RxNO) concentrations in
uncomplicated naturally conceived pregnancies. RxNO functions as a NO storage pool [47], and lower
RxNO levels may reflect higher utilization of this alternative source of NO. Furthermore, diastolic
blood pressure is higher in women with an uncomplicated oocyte donation pregnancy with nitrite
serum concentrations below the median compared to women with concentrations above the median
(Figure 2D). The importance of NO in the regulation of blood pressure in pregnancy is shown in an
animal experiment where NO production was blocked in virgin and pregnant rats. The blockage
of NO synthases resulted in the development of hypertension in pregnant rats as well as in virgin
rats. Moreover, pregnant animals are more sensitive for NO synthesis blockade than non-pregnant
animals [58]. Thus, higher serum nitrite concentrations in women with uncomplicated oocyte donation
pregnancies could indicate a role of this NO metabolite in the regulation of vascular tone, which might
function as a compensatory mechanism in uncomplicated oocyte donation pregnancies to prevent a
further increase in blood pressure caused by the genetic incompatibility between mother and fetus in
oocyte donation pregnancies. However, we cannot exclude other possible explanations, such as the
increased maternal age in women pregnant after oocyte donation.
Study limitations include the small group size of women with oocyte donation complicated by
pre-eclampsia, which was a direct consequence of the definition of case selection criteria. We were
concerned that the results could be influenced by the duration of sample storage and therefore opted to
select samples from a defined study period to avoid this potential influence. Another limitation of our
study is that maternal age and gestational age were different between study groups. Maternal age is
an important risk factor for pre-eclampsia and could influence the rate of production and metabolism
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of reactive species [27,41,59]. Since women pregnant after oocyte donation are usually older, it is
difficult to match maternal age between naturally conceived and oocyte donation pregnancies.
Nevertheless, none of the measured molecules was associated with maternal age. Likewise, due to
the presence of pre-eclampsia (and the consequent preterm delivery), matching for gestational age
is difficult. A preterm control group does not exist due to the underlying factors leading to preterm
delivery. Lastly, the dietary intake of nitrite, nitrate and sulfate by the study participants, which could
affect the RSI status [41,60] and constitute an analytical confounding factor, was not determined.
4. Materials and Methods
4.1. Study Participants and Biospecimen Collection
A retrospective case-control study was performed in women pregnant after oocyte donation or
natural conception, and delivered in the Leiden University Medical Center (LUMC) and peripheral
hospitals in the Leiden region between 2012 and 2016. Maternal age, gestational age, highest diastolic
blood pressure, and presence of pre-eclampsia were documented. Different groups were clinically
matched for BMI, smoking habits, gravidity, parity, and mode of delivery. This study was carried out
following the rules of the Declaration of Helsinki and collection of samples was approved by the ethics
committee of the Leiden University Medical Center (P13.084, 17 June 2013). All subjects gave their
informed consent for inclusion before they participated in the study.
4.2. Clinical Definitions
Miscarriage was defined as the spontaneous loss of pregnancy within the first 24 weeks of
gestation [61,62]. Termination of pregnancy was defined as a termination on a medical fetal or
maternal indication within the first 24 weeks of pregnancy resulting in fetal demise (Dutch guideline
on termination of pregnancy until 24 weeks of gestational age; [63]). Abortion was when pregnancy loss
was induced within the first 24 weeks of gestation for social reasons [64]. IUFD was defined as fetal loss
after 24 weeks of gestation. Gestational hypertension was defined as de novo hypertension (systolic
blood pressure ≥ 140mmHg and/or diastolic blood pressure ≥ 90 mmHg) after gestational week
20. Pre-eclampsia was defined as de novo hypertension after gestational week 20 and new onset of
proteinuria (≥300 mg/24 h or a spot urine protein creatinine ratio ≥ 30 mg/mmol), renal insufficiency,
liver disease, neurological problems, haematological disturbances or fetal growth restriction [65].
A term pregnancy was defined as childbirth after 37 weeks of pregnancy, and preterm birth was
defined as birth between 24–37 weeks of gestation. Small for gestational age was defined as a birth
weight below the 10th percentile for gestational age according to the Dutch reference curves for birth
weight by gestational age [66]. Gestational diabetes is defined as onset or first recognition of abnormal
glucose tolerance during pregnancy.
4.3. Measurements
Serum samples were collected in the third trimester and stored at −80 ◦C until measurements.
The concentrations of the following analytes of the RSI were measured in serum: Total free thiols,
protein bound NO (RxNO), nitrite (NO2−), nitrate (NO3−), 8-iso-prostaglandin F2a (isoprostanes),
sulfate (SO42−) and thiosulfate (S2O32−).
4.3.1. Colorimetric Detection of Total Free Thiol Groups
Free thiols were detected using Ellman’s reagent as described previously [67,68]. Briefly, serum
samples were diluted 1:3 with Tris buffer (0.1 M, pH 8.2), and background absorbance was read at
412 nm using a microplate reader with reference at 630 nm. Then, 10 µL 5,5’-Dithio-bis(2-nitrobenzoic
acid) (DTNB; 3.8mM, Ellman’s Reagent) diluted in phosphate buffer (0.1 M, pH 7) was added.
The samples were incubated with DTNB for 20 min at room temperature, sample absorbance was
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measured again at 412 nm with 630 nm reference and compared to a calibration curve constructed for
L-cysteine under identical conditions.
4.3.2. Assessment of Nitroso Species via Gas Phase Chemiluminescence Detection
Protein bound nitric oxide (RxNO) concentrations in the serum were quantified using
reductive denitrosation by iodine-iodide with subsequent detection of liberated NO by gas-phase
chemiluminescence, as described elsewhere [46]. Samples were thawed for 30 min at room temperature
(RT) in the presence of N-ethylmaleimide (NEM; 10 mM final concentration), and nitrite was removed
by reaction with acifified sulphanilamide before injection into the septum-sealed reaction chamber
containing triiodide in glacial acetic acid as detailed previously [46].
4.3.3. Determination of Nitrite and Nitrate
The HPLC method used employs ion chromatography with on-line reduction of nitrate to
nitrite and subsequent post-column derivatization with the Griess reagent (ENO-20, Eicom, Kyoto,
Japan) [46]. Samples were subjected to deproteinization using ice-cold methanol (1:1 v/v) followed by
centrifugation. A total volume of 20 µL of sample was loaded onto the column, resulting in a detection
limit of 10 nM for either anion.
4.3.4. Total Free 8-Iso-Prostaglandin F2a Determination
Free 8-iso-prostaglandin F2a was measured by competitive ELISA using a commercial assay kit
(Cayman Chemical, Ann Arbor, MI, USA). The concentration of total (free + bound) 8-isoprostanes
was determined after subjecting serum to alkaline hydrolysis and a final dilution of 20-fold with assay
buffer before measurement.
4.3.5. Sulfate Determination
Serum sulfate concentrations were quantified by means of ion-exchange chromatography after
protein precipitation with methanol and a subsequent 10-fold dilution with ultrapure water.
4.3.6. Thiosulfate Determination
Thiosulfate was determined by HPLC following monobromobimane (MBB) derivatization,
as previously described [69–71]. Briefly, 25 µL of urine was derivatized with 5 µL of 46 mM MBB, 25
µL of acetonitrile, and 25 µL of 160 mM HEPES/16 mM EDTA pH 8 buffer for 30 min in the dark.
The derivatization reaction was stopped by addition of 50 µL of 65 mM methanosulfonic acid and
proteins were removed by centrifugation [71].
4.4. Statistical Analysis
Normally distributed continuous data were analysed using ANOVA and the least significant
differences as a post-hoc test. A log transformation of the data was performed based on the Levene’s test
and/or the distribution of the residuals. When a log transformation did not improve our analysis the
Tamhane correction for unequal variances was used. Categorical data were analysed using a Pearson
chi-square test, and when applicable a Fisher’s exact test for subgroup analysis. For correlations
between RSI metabolites clinical outcomes, Spearman’s rho was used. A p-value below 0.05 was
considered statistically significant. All analyses were performed using the SPSS statistics software
(Version 23, IBM Nederland B.V., Amsterdam, The Netherlands).
5. Conclusions
In conclusion, alterations in the RSI status are present in naturally conceived pregnancies as
well as in oocyte donation pregnancies complicated by pre-eclampsia, and the concentrations of
both total free thiols and sulfate are associated with the severity of pre-eclampsia in naturally
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conceived pregnancies. Furthermore, changes in the RSI status are also seen in uncomplicated
oocyte donation pregnancies compared to uncomplicated naturally conceived pregnancies. In this
study, a possible compensatory mechanism via the NO-pathway was found in uncomplicated oocyte
donation pregnancies. This exploratory study is the first that elucidated possible changes in select
readouts of the RSI in oocyte donation pregnancies. More research is warranted on the role of the
RSI in uncomplicated oocyte donation pregnancies and oocyte donation pregnancies complicated by
pre-eclampsia. Given that mitochondrial function and cellular energetics are intimately interconnected
to the extracellular redox status and modulated by several RSI constituents at multiple levels [41], it is
possible that the latter plays an important role in fetal development and the prevention of complications
in pregnancy.
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